PepGen Announces Appointment of James McArthur, Ph.D., as President and Chief Executive Officer
Seasoned biotech executive with deep experience and proven track record in successfully leading rare disease companies through rapid growth and development Boston, Mass. and Oxford, UK (February 4th, 2021) – PepGen, a biotechnology company focused on transforming the care of patients with neuromuscular diseases through the enhanced…